- Home
- Equipment
- usa maryland
- disease patient
Show results for
Refine by
Disease Patient Equipment Supplied In Usa Maryland
5 equipment items found
by:Gain Therapeutics, Inc. based inBethesda, MARYLAND (USA)
Krabbe disease is a severe neurodegenerative disorder caused by mutations in GALC, the gene that encodes the galactosylceramidase (GALC) enzyme. These mutations cause GALC misfolding and dysfunction, which leads to the toxic buildup up fats in the central nervous system (CNS) and ultimately leads to the demyelination and death of neurons. There is no cure for this ...
Manufactured by:Precision For Medicine, Inc. based inFrederick, MARYLAND (USA)
Clinical and research-grade leukopaks - mobilized or non-mobilized from healthy and diseased subjects, including oncology donors. ...
Manufactured by:Medispec based inGaithersburg, MARYLAND (USA)
Erectile Dysfunction Shock Wave Therapy (EDSWT) is an innovative approach to vasculogenic ED. Medispec’s ED1000 is a medical device that uses advanced acoustics technology based on electrohydraulic power. This technology has proven to be effective in cardiology, with recent success in reversible ischemic tissues of the heart. EDSWT utilizes low-intensity extracorporeal shock waves, focusing ...
Manufactured by:3CPM Company, Inc. based inSparks Glencoe, MARYLAND (USA)
3CPM: There is a Way to Cure Gastroparesis. Standardized Water load: Designed to be used to study the true depth of Electrogastrography and the ability to diagnose various neuro-dysfunctions as related to the digestive system, in the uniform environment of the classic Water load testing protocol. It is the only EGG system that uses health normal data for comparison and to derive myoelectrical ...
Manufactured by:United Therapeutics Corporation based inSilver Spring, MARYLAND (USA)
Remodulin is a prostacyclin vasodilator indicated for the treatment of pulmonary arterial hypertension (PAH; WHO Group 1) to diminish symptoms associated with exercise. Studies establishing effectiveness included patients with NYHA Functional Class II-IV symptoms and etiologies of idiopathic or heritable PAH (58%), PAH associated with congenital systemic-to-pulmonary shunts ...